Clinical trial registry record

Taurine Supplementation Associated or Not With Exercise: Effect on Browning of White Adipose Tissue in Elderly Women With Sarcopenic Obesity

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated November 29, 2023.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05415176
Last registry update
November 29, 2023
Status
Unknown
Phase
Phase not reported
Sponsor
University of Sao Paulo
Enrollment
40
Countries
Brazil
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · TRIPLE
Evidence population
Human clinical study registration
Participants
40
Population
FEMALE · 60 Years to 75 Years
Duration
2023-02-27 to 2024-06-01
Intervention
Taurine supplementation; Pshysical exercise; Placebo control
Comparator
Placebo (Cont)
Outcomes measured
Browning of white adipose tissue — 16 weeks; Changes in metabolic parameters - fasting blood glucose — 16 weeks; Changes in metabolic parameters - lipid profile — 16 weeks; Changes in metabolic parameters - insulin sensitivity — 16 weeks; Body composition changes — 16 weeks; Improvement of physical performance — 16 weeks; Indirect calorimetry assessment — 16 weeks; Changes in inflamatory markers — 16 weeks; Changes in subcutaneous white adipose tissue (sWAT) morphology — 16 weeks; Changes in Lipidomic profile of sWAT — 16 weeks; Changes in plasma taurine — 16 weeks; Changes in plasma irisin — 16 weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Taurine · 100%Title contains controlled term: taurine. Abstract contains controlled term: taurine. Source terminology contains: taurine. Title supplies longevity context: elderly. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

taurine
Open primary sourceExport JSON